SLIDE 1
Science and Government
Professor Dame Sally C. Davies FRS FMedSci Chief Medical Officer & Chief Scientific Adviser
- The role of scientists
- Introducing evidence into policy
Science and Government The Royal Society 9 July 2014 Professor - - PowerPoint PPT Presentation
Science and Government The Royal Society 9 July 2014 Professor - - PowerPoint PPT Presentation
Science and Government The Royal Society 9 July 2014 Professor Dame Sally C. Davies FRS FMedSci Chief Medical Officer & Chief Scientific Adviser The role of scientists Introducing evidence into policy The role of scientists
SLIDE 2
SLIDE 3
- The role of scientists
- Introducing evidence into policy
SLIDE 4
Clinical research and the NHS
1988 House of Lords report 1998 Culyer Declaration 2005 Review of R&D budget barriers to research in the NHS
SLIDE 5
Barriers to clinical research
- Infrastructure
- Training (fewer clinical academics)
- Research funding (historical, low)
- Governance
- Lack of incentives
SLIDE 6
Drivers for change
- Evidence based medicine
- Technology / infrastructure platforms
- Reducing bureaucracy
SLIDE 7
- improve health outcomes through
advances in research
- improve quality of care by NHS
participation in the research process
- strengthen International competitive
position in science
- drive economic growth through
investment by life science industries
Why is the Government committed to Research in the NHS? Health and Wealth
SLIDE 8
Infrastructure
Clinical Research Facilities, Centres & Units Clinical Research Networks
Research
Research Projects & Programmes Research Management Systems Research Information Systems
Systems
Patients & Public Universities
Investigators & Senior Investigators Associates
Faculty
Trainees Research Schools
NHS Trusts
NIHR Health Research System
SLIDE 9
The NIHR Network portfolio: supporting Industry
At the end of 2013/14, the Network was supporting 733 recruiting commercial contract studies – the highest number since records began in 2008/09
SLIDE 10
NIHR BRCs / BRUs leveraged funding
SLIDE 11
Recruitment and retention
Source: Medical Schools Council survey of staffing levels of medical Clinical Academics in UK medical schools (31 July 2013)
500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 FTE Professor Reader/ Senior Lecturer Lecturer Grand Total
NIHR Established
Clinical academic careers
SLIDE 12
SLIDE 13
Major NIHR infrastructure platforms
- NIHR BioResource
- NIHR Translational Research Collaborations
– Dementia – Rare diseases
- Translational Research Partnerships
– Inflammatory Respiratory Diseases – Joint and Related Inflammatory Diseases
- Genomics England: 100,000 whole genomes
- UK BioBank
- BioSample Repository
- MRC–NIHR Phenome Centre
- The Francis Crick Institute
SLIDE 14
Major NIHR infrastructure platforms
- NIHR BioResource
- NIHR Translational Research Collaborations
– Dementia – Rare diseases
- Translational Research Partnerships
– Inflammatory Respiratory Diseases – Joint and Related Inflammatory Diseases
- Genomics England: 100,000 whole genomes
- UK BioBank
- BioSample Repository
- MRC–NIHR Phenome Centre
- The Francis Crick Institute
SLIDE 15
- The role of scientists
- Introducing evidence into policy
SLIDE 16
Annual Report of the Chief Medical Officer
- Independent
- Surveillance
- Advocacy
SLIDE 17
Annual reports 2011/2012
SLIDE 18
Surveillance 2011
SLIDE 19
Surveillance 2012
SLIDE 20
Infections and AMR
Drug Resistant
- E. Coli
(30% mortality)
- E. Coli 36%
Klebsiella 7.8%
SLIDE 21
AMR - a cross government priority
- WHA resolution
- agenda item G7 science ministers and
Carnegie Group
- WISH forum
- 5 year UK strategy
- Longitude prize topic
- Independent commission of R&D pipeline
SLIDE 22
Science and Government
Professor Dame Sally C. Davies FRS FMedSci Chief Medical Officer & Chief Scientific Adviser
The Royal Society 9 July 2014
SLIDE 23